Richmond Pharmacology to provide Immediate Life Support (ILS) Courses
Posted:
31
July 2019
In line with our on-going commitment to providing quality training and promoting the highest safety standard, Richmond Pharmacology are pleased to announce that our ILS
Richmond Pharmacology to provide Immediate Life Support (ILS) Courses
In line with our on-going commitment to providing quality training and promoting the highest safety standard, Richmond Pharmacology are pleased to announce that our ILS Courses are now open to the public. In association with the Resuscitation Council UK, Richmond Pharmacology’s highly trained Resuscitation and Clinical Skills Practitioners will equip external healthcare professionals with the skills to assist patients in preventing or treating cardiac arrest.
To register your interest, or to find out more about the training offered by Richmond Pharmacology, please click here.Additionally, to find out more about the ILS training courses offered by the Resuscitation Council (UK), please check here.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
